i spoke w/ chris/opco analyst this am. many analysts thought yday's conf call was going to be about lupus and a few minor items. therefore, this PM/DM and doc levine was total upside surprise. further, as much as the company is trying to tame expectations by saying this is earlier than the NS development, it's hard to argue their confidence level of hiring 12 initial reps asap vs. just 5 for NS when they started that trial. in other words, my gut feel is that this new area will ramp up quite nicely.